Study finds no elevated risk of thyroid cancer among GLP1-RA users

by

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer.

Leave A Comment

Your email address will not be published. Required fields are marked *